Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Based on the creator handle @fusionbiotech and the peptide category tag, this video is almost certainly making a case for one or more research peptides, likely BPC-157, TB-500, CJC-1295, ipamorelin, or GHK-Cu. The TikTok Creator Search Insights hashtag suggests the creator is optimizing for discovery, meaning the content is probably framed around a trending question like "does BPC-157 actually work" or "what peptides do for recovery." Expect claims about accelerated tissue healing, growth hormone stimulation, anti-aging effects, or cognitive enhancement. These creators frequently position peptides as a smarter, cleaner alternative to anabolic steroids or pharmaceutical drugs. Some go further and imply that compounded peptide vials available online are equivalent to clinical-grade research compounds. That last move is where things get legally and medically problematic fast.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and the human data is thin across the board. BPC-157 has shown genuine promise in rodent models, with Sikiric et al. (2018, Current Pharmaceutical Design) documenting accelerated tendon and gut healing in rats, but zero completed randomized controlled trials in humans as of 2024. TB-500, a synthetic fragment of thymosin beta-4, has one phase II trial in cardiac patients (Goldstein et al., 2012, Journal of Cardiovascular Pharmacology) showing modest safety signals, not efficacy for the gym recovery use case it's marketed for. CJC-1295 combined with ipamorelin does stimulate growth hormone release, with Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) showing GH pulse amplification, but the downstream benefits for body composition in healthy adults remain poorly quantified. GHK-Cu shows interesting in vitro collagen synthesis data but controlled human skin trials are small and industry-funded. The gap between animal pharmacology and clinical reality is substantial here.

Where does the social media noise diverge from clinical reality?

The biggest divergence is dosing confidence. TikTok peptide content routinely states specific milligram doses and injection protocols as though they're established clinical standards. They are not. These doses are extrapolated from animal studies or anecdotal bodybuilding forums, not from dose-ranging trials in humans. A second major divergence is the framing of peptides as uniformly safe because they're "naturally occurring" or "your body already makes them." Endogenous doesn't mean exogenous administration is safe at pharmacological doses. MK-677, frequently grouped with peptides despite being a small molecule ghrelin mimetic, has a published case series linking chronic use to insulin resistance and edema (Murphy et al., 1998, Journal of Clinical Endocrinology and Metabolism covered early GH secretagogue effects). A third problem is regulatory status. In the US, most of these compounds are not FDA-approved for therapeutic use. The FDA placed BPC-157 on its bulk drug substances list in 2023, effectively restricting compounding pharmacies from producing it for clinical use.

What should you actually know?

If you're watching a TikTok about peptides and the creator is not a licensed prescriber working within a regulated telehealth framework, treat the content as enthusiasm, not medical guidance. Some peptides have genuinely interesting mechanistic data and a small number are used in supervised clinical settings for specific indications. GHK-Cu in topical formulations has reasonable cosmetic data. Sermorelin, a GHRH analog, has a longer clinical track record than the newer secretagogues. Semax and selank, developed in Russia, have some published pharmacological data but essentially no Western RCT evidence. The core problem isn't that peptides are worthless. It's that social media compresses decades of research uncertainty into a 60-second confidence display. Anyone offering a peptide protocol without bloodwork, a documented clinical indication, and ongoing monitoring is operating outside responsible medical practice. That's not an opinion, it's the regulatory and ethical baseline.